Insulin is not the only weapon? Is insulin another tool we have to deal with diabetes?
Such a possibility was created in a recent study. Researchers have found that this is the first time that a new weapon in the fight against diabetes has been found in the fat tissues of the human body. Whose name is ‘FGF1’.
The study, by researchers at the Salk Institute in the United States, was published in the international scientific research journal Cell Metabolism.
According to researchers, FGF1, a substance found in fat cells in the human body, acts just like insulin. Reduces high blood sugar levels skillfully.
This substance is basically a hormone. This hormone rapidly lowers the level of excess sugar in the blood by controlling the process of fat breakdown (‘lipolysis’).
Experts say that new drugs made with this hormone can play a very important role in curing type 2 diabetes.
Researchers also say that although it acts like insulin, this hormone in fat cells works in a different way. Therefore, those who do not have the right amount of insulin in their body can find an alternative way to quickly reduce the level of excess sugar in the blood.
When we eat something, the high calorie fat and glucose in the food are mixed with the plasma and enter the veins and arteries. Their circulation with blood also begins throughout the body. Insulin builds a barrier to their veins and arteries. But for those whose body does not secrete enough insulin or the normal functioning of insulin is disrupted for any reason, it becomes difficult to prevent the intake of high calorie fats and glucose in the veins and arteries. Not only this, with the help of fire you can do welding. As a result, the levels of fatty acids in the body increase abnormally.
The patient can be brought back to life from brain death! In a recent study, researchers found that the hormone Hadeesh Mela was not the only insulin supplement; The use of this hormone can also eliminate the complications of insulin secretion in the body.
Researchers have found that the drug dapaglyphlogine, which is effective in controlling blood sugar levels, can reduce the risk and death of a variety of complex heart diseases, including heart attack, in patients with type 2 diabetes.
The study was conducted jointly by Manash University and Baker Heart and Diabetes Institute. The experiment was carried out in the laboratory. No clinical trial yet. The researchers aim to find out how effective other drugs in the diabetes market may be.
According to Karin Jandelit-Dam, a diabetes specialist at Manash University, one of the leading researchers, atherosclerosis is more common in people with type 2 diabetes. It is a disease in which excess fat accumulates in the inner wall of the artery.
As a result, the blood flow in the arteries stops. The result is a variety of complex heart diseases, including heart attacks. All of these diseases are now the leading cause of death for diabetics worldwide.